In the BioHarmony Drug Report Database

"Preview" Icon

Amlodipine besilate

Amlodipine Besylate, Norvasc (amlodipine besylate) is a small molecule pharmaceutical. Amlodipine besylate was first approved as Amlodipine Besylate on 1992-07-31. It is used to treat coronary artery disease, hypertension, and variant angina pectoris in the USA. It is known to target voltage-dependent L-type calcium channel subunit alpha-1D and voltage-dependent L-type calcium channel subunit alpha-1C. Norvasc’s patent is valid until 2022-11-20 (FDA).

 

Trade Name

 

Amlodipine Besylate, Norvasc
 

Common Name

 

amlodipine besylate
 

ChEMBL ID

 

CHEMBL1200402
 

Indication

 

coronary artery disease, hypertension, variant angina pectoris
 

Drug Class

 

Phenylpyridine vasodilators (nifedipine type)

Image (chem structure or protein)

Amlodipine besilate structure rendering